Holen Sie sich die Stockscreener-App
279.18
1.36%
3.75
Handel nachbörslich:
280.65
1.47
+0.53%
Schlusskurs vom Vortag:
$275.43
Offen:
$276.77
24-Stunden-Volumen:
909.54K
Relative Volume:
0.63
Marktkapitalisierung:
$45.62B
Einnahmen:
$2.86B
Nettoeinkommen (Verlust:
$780.66M
KGV:
59.15
EPS:
4.72
Netto-Cashflow:
$1.20B
1W Leistung:
-1.23%
1M Leistung:
+1.19%
6M Leistung:
+19.23%
1J Leistung:
+46.69%
1-Tages-Spanne:
$273.88
$279.33
1-Wochen-Bereich:
$272.77
$286.82
52-Wochen-Spanne:
$187.66
$296.72
Veeva Systems Inc Stock (VEEV) Company Profile
Firmenname
Veeva Systems Inc
Sektor
Branche
Telefon
925-452-6500
Adresse
4280 HACIENDA DRIVE, PLEASANTON, CA
Vergleichen Sie VEEV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
279.18 | 45.01B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
69.63 | 11.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.27 | 8.00B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-29 | Bestätigt | Needham | Buy |
| 2025-01-23 | Herabstufung | Goldman | Buy → Sell |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-19 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-08-27 | Bestätigt | Citigroup | Buy |
| 2024-07-09 | Eingeleitet | BTIG Research | Buy |
| 2023-10-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | Eingeleitet | Jefferies | Buy |
| 2023-06-28 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-17 | Herabstufung | Truist | Buy → Hold |
| 2023-02-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-12-06 | Eingeleitet | Cowen | Market Perform |
| 2022-12-02 | Bestätigt | Needham | Buy |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | Goldman | Buy |
| 2022-06-21 | Fortgesetzt | Guggenheim | Buy |
| 2022-03-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2022-01-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Fortgesetzt | Stifel | Buy |
| 2021-09-02 | Bestätigt | BofA Securities | Buy |
| 2021-09-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2021-09-02 | Bestätigt | Needham | Buy |
| 2021-09-02 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Eingeleitet | Cowen | Outperform |
| 2021-03-31 | Hochstufung | UBS | Sell → Neutral |
| 2021-01-07 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-10-14 | Fortgesetzt | UBS | Sell |
| 2020-08-28 | Bestätigt | Needham | Buy |
| 2020-07-23 | Eingeleitet | FBN Securities | Outperform |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-06-08 | Eingeleitet | Citigroup | Buy |
| 2020-05-29 | Bestätigt | Needham | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-02-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-14 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | Bestätigt | Canaccord Genuity | Hold |
| 2019-09-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | Bestätigt | Needham | Buy |
| 2019-06-07 | Eingeleitet | Goldman | Neutral |
| 2019-05-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-27 | Bestätigt | Needham | Buy |
Alle ansehen
Veeva Systems Inc Aktie (VEEV) Neueste Nachrichten
Reasons to Add Veeva Systems Stock to Your Portfolio for Now - MSN
Veeva Systems Shares Dip 0.55% as Trading Volume Surges 60% to 310th Rank - AInvest
Research Shows Medtechs Prioritizing Site Collaboration and Data Quality - Veeva
Veeva Systems shares rise 1.16% premarket after announcing findings from the 2025 Veeva MedTech Clinical Benchmark. - AInvest
MedTech Clinical Trials Face Digital Gap: Only 14% of Large Companies Have Modern Site Tools - Stock Titan
eClinical Solutions Market Key Players AnalysisMedidata, Veeva Systems, Iqvia Inc., Icon Plc, Signant Health. - openPR.com
Veeva Systems Dips on 469th-Ranked Volume as Institutions Boost Holdings Amid Insider Share Sales - AInvest
2 Reasons to Watch VEEV and 1 to Stay Cautious - ca.finance.yahoo.com
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Is Veeva Systems Inc. in a consolidation phase3x Potential Swing Trade Ideas - thegnnews.com
Veeva Rises 0.85% as Trading Volume Falls to 413th Rank Amid Earnings Anticipation and Analyst Upgrade - AInvest
Veeva Stock Plummets 1.02% as Volume Surges 65% to Rank 325th in Activity - AInvest
Veeva Systems (VEEV) Declines More Than Market: Some Information for Investors - Yahoo Finance
Veeva Systems Inc. (VEEV): A Bull Case Theory - MSN
Veeva Q2 FY26 Earnings Call Scheduled: How to Access Financial Results August 27 - Stock Titan
Veeva Systems Tumbles 8.5% as Healthcare IT Sector Struggles with AI Hype Ranks 423rd in $290 Million Volume - AInvest
Veeva (VEEV) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Patient Data Hub Solutions Market Size, Share & Trends - GlobeNewswire
Patient Data Hub Solutions Market Size, Share & Trends Analysis Report 2025-2033, with Profiles of IQVIA, WellSky, Veeva Systems, Capgemini, Optum, ZS, Equipo Health, NXGN Management, and IntegriChain - Yahoo Finance
Veeva Systems and Sarah Cannon Partner to Accelerate Cancer Clinical Trials - MSN
Veeva Systems Gains 1.4% on AI Momentum Ranks 368th in 300M Dollar Daily Trading Volume - AInvest
Assessing Veeva Systems' Financial Health Through Return on Equity - AInvest
Is Veeva Systems Inc.'s (NYSE:VEEV) Latest Stock Performance A Reflection Of Its Financial Health? - Yahoo Finance
Breaking Silos in Cross-Functional KOL Engagement: Q&A with Astellas - Veeva
Does Veeva Systems Inc. stock perform well during market downturnsInvest confidently with professional market insights - Jammu Links News
Is Veeva Systems Inc. a good long term investmentFree Investment Community - Jammu Links News
Is Veeva Systems Inc. stock overvalued or undervaluedOutstanding investment returns - Jammu Links News
How volatile is Veeva Systems Inc. stock compared to the marketConsistently high yield - Jammu Links News
How strong is Veeva Systems Inc. company’s balance sheetBreakout stock performance - Jammu Links News
Is it the right time to buy Veeva Systems Inc. stockFree Predictions - Jammu Links News
What are Veeva Systems Inc. company’s key revenue driversHigh-octane gains - Jammu Links News
What are the latest earnings results for Veeva Systems Inc.Free Predictions - Jammu Links News
What is Veeva Systems Inc. company’s growth strategyFree Stock Market Return Analysis - Jammu Links News
Published on: 2025-08-03 15:07:21 - Jammu Links News
How does Veeva Systems Inc. generate profit in a changing economyFree Bull & Bear Market Updates - Jammu Links News
Is Veeva Systems Inc. a growth stock or a value stockMaximize your portfolio’s earning potential - Jammu Links News
What catalysts could drive Veeva Systems Inc. stock higher in 2025Achieve consistent double-digit returns - Jammu Links News
When is Veeva Systems Inc. stock expected to show significant growthNavigate market volatility with smart strategies - Jammu Links News
How many analysts rate Veeva Systems Inc. as a “Buy”Master the art of timing market moves - Jammu Links News
Veeva Systems Slides 1% on 280M-Dollar Volume as AI Rivals Challenge Healthcare Software Leadership - AInvest
Veeva Systems (VEEV) Stock Moves -1.09%: What You Should Know - Nasdaq
Veeva Systems Inc Class A to Host Earnings Call - ACCESS Newswire
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition? - Nasdaq
Veeva Systems Stock Is Up Nearly 40% This Year And Approaching A Buy Point - MSN
There's Reason For Concern Over Veeva Systems Inc.'s (NYSE:VEEV) Price - 富途牛牛
What are the technical indicators suggesting about Veeva Systems Inc.Financial News Planner For Consistent Profits - jammulinksnews.com
Veeva Systems Slides to 396th in Daily Trading Volume Despite AI-Driven Growth and Merck Partnership - AInvest
Why is Veeva Systems Inc. stock attracting strong analyst attentionPre Market Insights For Beginners - jammulinksnews.com
Finanzdaten der Veeva Systems Inc-Aktie (VEEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.96%
3.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):